FAM
MDGL icon

Fred Alger Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Fred Alger Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,039
Closed -$544K – 466
2026
Q1 		$544K Buy
+1,039
New +$496K ﹤0.01% 380
2024
Q4 		– Sell
-93,446
Closed -$19.8M – 449
2024
Q3 		$19.8M Sell
93,446
-9,009
-9% -$2.3M 0.1% 134
2024
Q2 		$28.7M Buy
102,455
+37,879
+59% +$9.02M 0.14% 102
2024
Q1 		$17.2M Buy
64,576
+46,479
+257% +$11M 0.09% 157
2023
Q4 		$4.19M Sell
18,097
-1,767
-9% -$309K 0.02% 265
2023
Q3 		$2.9M Buy
19,864
+456
+2% +$85.8K 0.02% 291
2023
Q2 		$4.48M Sell
19,408
-1,458
-7% -$395K 0.02% 259
2023
Q1 		$5.05M Buy
20,866
+4,746
+29% +$1.29M 0.03% 254
2022
Q4 		$4.68M Buy
+16,120
New +$1.58M 0.03% 267
2019
Q3 		– Sell
-11,000
Closed -$1.15M – 522
2019
Q2 		$1.15M Sell
11,000
-7,333
-40% -$785K ﹤0.01% 331
2019
Q1 		$2.3M Sell
18,333
-195
-1% -$24.2K 0.01% 276
2018
Q4 		$2.09M Buy
18,528
+5,782
+45% +$895K 0.01% 280
2018
Q3 		$2.73M Sell
12,746
-2,282
-15% -$573K 0.01% 265
2018
Q2 		$4.2M Buy
15,028
+6,028
+67% +$1.06M 0.02% 239
2018
Q1 		$1.05M Buy
9,000
+3,000
+50% +$370K ﹤0.01% 333
2017
Q4 		$551K Buy
+6,000
New +$343K ﹤0.01% 365

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fred Alger Management's MDGL Position: Q2 2026 in Review

Fred Alger Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 1,039 shares — an estimated $544K sold.

Fred Alger Management first reported a position in MDGL in Q4 2017 and held it in 16 quarters. The position peaked at $28.7M in Q2 2024. 415 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Fred Alger Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Fred Alger Management sold 1,039 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $544K.
  • Fred Alger Management first reported a position in Madrigal Pharmaceuticals in Q4 2017 and held it in 16 quarters.
  • Fred Alger Management's Madrigal Pharmaceuticals position peaked at $28.7M in Q2 2024.
  • 415 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.